Tools chosen: kalshi_direct claude_news gdelt_news wikipedia kalshi_related polymarket_related

Sub-questions (Fermi decomposition)

Planner reasoning

This resolves Yes if any year 2024-2029 has zero reported wild poliovirus type 1 (WPV1) cases globally. The key is the current trajectory of WPV1 cases, which remain endemic only in Pakistan and Afghanistan, plus any outbreaks elsewhere. Recent case counts and eradication program progress are the decisive empirical inputs.

# Current state WPV1 transmission remains active in both endemic countries (Pakistan and Afghanistan) in 2026, with cases already reported this year. Resolution requires zero reported WPV1 cases in any single calendar year between 2024–2029. # Timeline of key events - **2023**: Low WPV1 case count (baseline for comparison; ~6 Pakistan, ~6 Afghanistan per implied "12-fold / 4-fold increase" language) [WHO, confirmed] - **2024**: 99 WPV1 cases total — 74 Pakistan, 25 Afghanistan; 12-fold increase in Pakistan, 4-fold in Afghanistan vs. 2023 [Wikipedia/GPEI, confirmed] - **2025-04-10**: WHO IHR Emergency Committee (41st meeting) flags surging 2024 cases and cross-border transmission risk [WHO, confirmed] - **2025 (full year)**: 51 WPV1 cases — 31 Pakistan, 21 Afghanistan; 661 positive environmental samples Pakistan, 90 Afghanistan; 3 positive environmental samples in Germany [Wikipedia, confirmed] - **2025-07/2025-11**: WHO IHR Emergency Committees (42nd, 43rd) continue PHEIC; early 2025 GPEI benchmarks not met [WHO, confirmed] - **2025-10**: GPEI Action Plan 2026 released; 18% funding cut absorbed; certification target remains end-2027 [GPEI, confirmed] - **2026-05**: New WPV1 cases in Pakistan (Karachi, 5 cases; 2 more separately); poliovirus detected in Perth wastewater (overseas-linked) [GDELT/news, confirmed] - **2026-06**: Afghanistan 2026 total reaches 6 WPV1 cases; "Polio-Free Afghanistan" advocacy call issued [Khaama, confirmed] - **2026-06**: Attacks on health workers complicating campaigns in Pakistan [IANS, confirmed] --- # Event Will any single calendar year (2024–2029) record zero reported wild poliovirus type 1 (WPV1) cases globally? # Outcomes to forecast - **Yes**: At least one year in 2024–2029 has zero WPV1 cases - **No**: Every year 2024–2029 has ≥1 WPV1 case # Kalshi market anchor **Current YES price: 10.70%** — up +5.50% over 7 days, +3.50% over 30 days. Range over 43 days: 4.30%–10.70%. Volume: ~307 contracts/day. Recent upward drift may reflect improved 2025 case trajectory vs. 2024 peak, but market remains heavily skewed toward No. # Sub-question answers 1. **WPV1 cases in 2023 and 2024?** — 2023: implied ~6 Pakistan + ~6 Afghanistan (~12 total) based on WHO's "12-fold / 4-fold increase" language. 2024: 99 cases (74 Pakistan, 25 Afghanistan). [WHO/Wikipedia] 2. **Trend in Pakistan and Afghanistan?** — Sharp surge in 2024 (99 cases) after low 2023; partial improvement in 2025 (51 cases). 2026 already has cases accumulating (Pakistan ~7+, Afghanistan ~6 as of June 2026). Trend is down from 2024 peak but far from zero. [WHO, GDELT] 3. **WPV1 outside endemic countries?** — No paralytic cases outside Pakistan/Afghanistan, but positive environmental detections in Germany (2025) and Perth wastewater (2026, overseas-linked). Export risk is real but paralytic cases remain confined. [Wikipedia, ABC Australia] 4. **WHO/GPEI eradication timeline?** — Official target: interrupt and certify WPV1 eradication by end-2027. Early 2025 benchmarks missed. 18% funding cut. Certification requires 3 consecutive years without cases — even a 2027 zero-case year couldn't yield certification before 2030. [GPEI, WHO] # Key facts (high-confidence, factual) 1. [Wikipedia/GPEI] 2024: 99 WPV1 cases; 2025: 51 WPV1 cases — both years clearly non-zero 2. [GDELT, June 2026] WPV1 cases confirmed in Pakistan and Afghanistan in 2026 — non-zero year already 3. [WHO, Nov 2025] GPEI's official interruption target is end-2027; early 2025 milestones not met 4. [GPEI Action Plan 2026] 18% funding reduction in 2025; primary acute threat to progress 5. [Wikipedia] Eradication certification requires 3 consecutive zero-case years with reliable surveillance 6. [WHO] Cross-border Pakistan-Afghanistan migrant movement sustains transmission reservoir 7. [GDELT] Attacks on health workers in Pakistan (2026) actively hampering campaigns # Cross-market signals - **Kalshi related**: Only market identified is KXPOLIOELIM-30 itself (10.70% YES) - **Polymarket**: No matching markets found - **Sportsbook**: N/A # Analyst opinions and speculation - PMC/NIH (2025): Funding cuts represent "primary, acute challenge" that could reverse all progress [PMC12568124] - GPEI (2026 Action Plan): Optimistic about 2027 target but acknowledges missed benchmarks - The recent price uptick (+5.5% in 7 days) may reflect market participants noting the 2025 case decline from 2024 peak, but 2026 data already shows ongoing transmission # Directional lean per outcome - **Yes (zero cases in any year 2024–2029)**: - *Supporting*: 2025 showed improvement (51 vs. 99 cases); 2024–2029 window includes 4 remaining years (2026 already non-zero); rapid vaccination surges occasionally surprise - *Opposing*: 2024, 2025, and 2026 all confirmed non-zero; GPEI missed benchmarks; funding cuts; attacks on workers; environmental detections spreading; 3 years remain (2027–2029) - **No**: Strongly supported by all current data; transmission entrenched; structural barriers (Taliban governance, security, funding) unresolved # Gaps / unknowns - Full 2026 case count unknown (accumulating) - Effectiveness of 2026 vaccination campaigns in Pakistan (18.6M children vaccinated — scale is large) - Whether US/USAID funding cuts materially reduce GPEI operations in 2026–2027 - Taliban cooperation with vaccination campaigns remains variable # Calibration anchors - **Kalshi current YES price: 10.70%** (primary anchor) - 2026 is already non-zero, leaving only 2027, 2028, 2029 — three years for a zero to occur - Historical base rate: WPV1 has never reached zero in the post-Nigeria era (2017–present); closest was 2022 (~30 cases) - GPEI's own optimistic scenario (zero by end-2027) implies ~3 years needed post-interruption for certification; probability of hitting zero in exactly 2027, 2028, or 2029 is low given 2026 trajectory - Reasonable independent estimate: ~8–13% YES, consistent with Kalshi anchor

1. Both forecasters correctly note that 2024, 2025, and 2026 are confirmed non-zero, leaving only 2027–2029, but neither explicitly quantifies the conditional probability required: to get YES, transmission must drop to zero in at least one of three remaining years starting from a 2026 baseline of already 13+ cases mid-year — a much steeper ask than the raw Kalshi price implies. 2. Neither forecaster engages with the historical base-rate asymmetry: the brief notes the closest WPV1 ever came to zero in the post-2017 era was ~30 cases in 2022, and even that was followed by a surge to 99 in 2024. This suggests the system is volatile and mean-reverting upward, which weakens the optimistic reading of the 2024→2025 decline as a durable trend. 3. The GPEI certification mechanism is underweighted as a diagnostic: the brief states certification requires 3 consecutive zero-case years, meaning GPEI's own "optimistic" end-2027 interruption target would produce the first zero-case year no earlier than 2027 — leaving zero slack before 2030. Both forecasters mention this but neither uses it to sharpen their probability downward from the Kalshi anchor. 4. The funding cut impact is treated qualitatively by both forecasters but not stress-tested: the brief cites PMC/NIH describing the 18% GPEI funding reduction as the "primary, acute challenge" that could reverse all progress, yet neither forecaster considers a scenario where 2027–2028 case counts rebound above 2025 levels due to reduced operations, which would make YES effectively impossible. 5. Neither forecaster flags the Perth wastewater detection and German environmental positives as evidence of broader cryptic circulation — meaning even if Pakistan/Afghanistan paralytic cases approach zero, surveillance gaps could produce a reported case from an unexpected geography, preventing a clean zero-case year.

7% (65% confidence)

Yes: 7% No: 93%

2024, 2025, and 2026 are all confirmed non-zero, leaving only 2027-2029 for a zero-case year. The critique correctly notes the steep conditional ask from a 2026 baseline of 13+ cases, the upward mean-reversion tendency (2022's low ~30 was followed by a surge to 99 in 2024), funding cuts as an acute reversal risk, and surveillance/environmental detections that could produce a reported case even if paralytic cases decline. These factors justify sitting slightly below the Kalshi anchor of 10.7%. I settle at 7% YES.

Total pipeline time: 144.1s